Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors

    Pancreatic neuroendocrine tumors (PNETs) with low microvessel density and fibrosis often exhibit clinical aggressiveness. Given the contribution of cancer-associated fibroblasts (CAFs) to the hypovascular fibr...

    Ting-Yu Lai, Tsai-Chen Chiang, Chih-Yuan Lee, Ting-Chun Kuo in British Journal of Cancer (2024)

  2. Article

    Open Access

    Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling

    Recurrence is one of the main causes of treatment failure in early-stage non-small cell lung cancer (NSCLC). However, there are no predictors of the recurrence of early-stage NSCLC, and the molecular mechanism...

    Hao Luo, Qing Li, Ren-Tao Wang, Liang Zhang in Experimental Hematology & Oncology (2023)

  3. Article

    Open Access

    Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

    Qian Zhu, Ai-Lin Zhong, Hao Hu, **g-**g Zhao in Journal of Hematology & Oncology (2023)

  4. No Access

    Article

    Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics

    Chimeric antigen receptor-modified T cells (CAR T-cells) have shown exhilarative clinical efficacy for hematological malignancies. However, a shared antigen pool between healthy and malignant T-cells remains a...

    Jiali Cheng, Yuyan Zhao, Hui Hu, Ling Tang, Yuhao Zeng in Cancer Immunology, Immunotherapy (2023)

  5. Article

    Open Access

    Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia

    Acute myeloid leukemia (AML) is a myeloid neoplasm makes up 7.6% of hematopoietic malignancies. Super-enhancers (SEs) represent a special group of enhancers, which have been reported in multiple cell types. In...

    Fang Fang, Jun Lu, Xu Sang, Yan-Fang Tao in Journal of Experimental & Clinical Cancer … (2022)

  6. Article

    Open Access

    Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction

    Interleukin-37b (hereafter called IL-37) was identified as fundamental inhibitor of natural and acquired immunity. The molecular mechanism and function of IL-37 in colorectal cancer (CRC) has been elusive. Her...

    Zhen Wang, Fan-lian Zeng, Ya-wen Hu in Signal Transduction and Targeted Therapy (2022)

  7. Article

    Open Access

    Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model

    Although the recent treatment in melanoma through the use of anti-PD-1 immunotherapy is successful, the efficacy of this approach remains to be improved. Here, we explore the feasibility of combination strateg...

    Hai-Jun Hu, **u Liang, Hai-Lang Li, Huai-Yuan Wang in Cancer Immunology, Immunotherapy (2021)

  8. Article

    Open Access

    Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer

    RNA exosome can target the specific RNAs for their processing/degradation by distinct exosome cofactors. As a key component in exosome cofactors, RNA binding motif protein 7 (RBM7) shows the binding specificit...

    Pei-Wen **, Xu Zhang, Lei Zhu, **n-Yuan Dai, Lin Cheng, Yue Hu in npj Breast Cancer (2020)

  9. No Access

    Article

    Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy

    The dismal outcome in patients with locally advanced or metastatic gastric cancer (GC) highlights the need for effective systemic neoadjuvant chemotherapy to improve clinical results. This study evaluated the ...

    Yung-Sung Yeh, Yi-Ting Chen, Hsiang-Lin Tsai in Pathology & Oncology Research (2020)

  10. Article

    Open Access

    Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

    Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms...

    Qian Zhu, Ai-Lin Zhong, Hao Hu, **g-**g Zhao in Journal of Hematology & Oncology (2020)

  11. No Access

    Article

    Acidosis promotes tumorigenesis by activating AKT/NF-κB signaling

    The microenvironment of solid tumors is often acidic due to poor vascular perfusion, regional hypoxia, and increased glycolytic activity of tumor cells. Although acidosis is harmful to most types of cells, tum...

    Liu Yang, **aoge Hu, Yin-Yuan Mo in Cancer and Metastasis Reviews (2019)

  12. Article

    Open Access

    CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation

    To construct a prediction model based on peritumoral radiomics signatures from CT images and investigate its efficiency in predicting early recurrence (ER) of hepatocellular carcinoma (HCC) after curative trea...

    Quan-yuan Shan, Hang-tong Hu, Shi-ting Feng, Zhen-peng Peng in Cancer Imaging (2019)

  13. Article

    Open Access

    Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

    Research has revealed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) may prevent cancers such as hepatocellular carcinoma (HCC). The comparative chemopreventi...

    Cheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, Jun-Fu Zhang, Jann-Yuan Wang in BMC Cancer (2018)

  14. Article

    Open Access

    Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling

    CLCA2 was reported as a tumor suppressor and disregulated in breast cancer. However, its function in tumor growth and metastasis in NPC has rarely been reported. In this study, we investigated the functional a...

    Yuan-Yuan Qiang, Chang-Zhi Li, Rui Sun in Journal of Experimental & Clinical Cancer … (2018)

  15. Article

    Open Access

    Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

    To evaluate the prognostic significance of pretreatment quality of life for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

    Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, Jian-Mei Li, Shi-Heng Zhu, Yan He in BMC Cancer (2018)

  16. No Access

    Article

    CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis

    The β-nitrostyrene family has been previously reported to possess anticancer property. However, the biological effects of β-nitrostyrenes on ovarian cancer and the underlying mechanisms involved remain unclea...

    Yen-Yun Wang, Yuk-Kwan Chen, Stephen Chu-Sung Hu in Cancer Chemotherapy and Pharmacology (2017)

  17. Article

    Open Access

    Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma

    An increasing number of targeted drugs have been tested for the treatment of nasopharyngeal carcinoma (NPC). However, targeted therapy-related oncogenic mutations have not been fully evaluated. This study aime...

    Jian-Wei Zhang, Tao Qin, Shao-Dong Hong, **g Zhang in Chinese Journal of Cancer (2015)

  18. Article

    Open Access

    SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway

    Gallbladder cancer (GBC) is a leading cause of cancer-related death worldwide, and its prognosis remains poor, with 5-year survival of approximately 5%. In this study, we analyzed the involvement of a novel pr...

    Yi-Jun Shu, Hao Weng, Yuan-Yuan Ye, Yun-** Hu, Run-Fa Bao, Yang Cao in Molecular Cancer (2015)

  19. Article

    Open Access

    Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors

    The optimal treatment for adrenal metastases from hepatocellular carcinoma (HCC) has not been established. This study analyzed the effects of radiation therapy (RT) for such metastases and identified clinical ...

    Le-Yuan Zhou, Zhao-Chong Zeng, Jia Fan, Bing Chen, Sheng-xiang Rao, Jian He in BMC Cancer (2014)

  20. Article

    Open Access

    Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements

    Estrogen forms a complex with the estrogen receptor (ER) that binds to estrogen response elements (EREs) in the regulatory region of estrogen-responsive genes and regulates their transcription. Sequence varian...

    Chia-Ni Hsiung, Hou-Wei Chu, Yuan-Ling Huang, Wen-Cheng Chou in Breast Cancer Research (2014)

previous disabled Page of 2